Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Insys Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - EX-31.1 - Insys Therapeutics, Inc. | d536565dex311.htm |
| EX-31.2 - EX-31.2 - Insys Therapeutics, Inc. | d536565dex312.htm |
| EX-32.2 - EX-32.2 - Insys Therapeutics, Inc. | d536565dex322.htm |
| 10-Q - FORM 10-Q - Insys Therapeutics, Inc. | d536565d10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Insys Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Periodic Report”), I, Michael L. Babich, President and Chief Executive Officer of the Company, certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
(1) The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2013, to which this Certification is attached as Exhibit 32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ Michael L. Babich | |
| Name: | Michael L. Babich | |
| Title: | President and Chief Executive Officer |
Date: June 5, 2013
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.